The Patent Finder

Respirerx Pharmaceuticals Inc.

Also on record
Records under this name other than the patents Respirerx Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 8 of 8 · Back to Respirerx Pharmaceuticals Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,642,633Di-substituted amides for enhancing glutamatergic synaptic responses
Lapsed on the fee record
Ended Feb 4, 2026 · USPTO record
Lapsed on the fee recordEnded Feb 4, 2026USPTO record
US 8,507,482Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
Lapsed on the fee record
Ended Aug 13, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 13, 2025USPTO record
US 8,404,682Di-substituted amides for enhancing glutamatergic synaptic responses
Lapsed on the fee record
Ended Mar 26, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 26, 2025USPTO record
US 9,492,440Bicyclic amides for enhancing glutamatergic synaptic responses
Lapsed on the fee record
Ended Nov 15, 2024 · USPTO record
Lapsed on the fee recordEnded Nov 15, 2024USPTO record
US 8,263,591Bicyclic amides for enhancing glutamatergic synaptic responses
Lapsed on the fee record
Ended Sep 11, 2024 · USPTO record
Lapsed on the fee recordEnded Sep 11, 2024USPTO record
US 8,168,632Bicyclic Amide Derivatives for the Treatmet of Respiratory Disorders
Lapsed on the fee record
Ended May 1, 2024 · Low confidence
Lapsed on the fee recordEnded May 1, 2024Low confidence
US 8,013,003Di-Substituted Amides for Enhancing Glutamatergic Synaptic Responses
Lapsed on the fee record
Ended Sep 6, 2023 · High confidence
Lapsed on the fee recordEnded Sep 6, 2023High confidence
US 8,110,584Methods for the Treatment of Respiratory Depression
Lapsed on the fee record
Ended Feb 7, 2020 · Medium confidence
Lapsed on the fee recordEnded Feb 7, 2020Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited